These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22734794)

  • 1. The management of antithrombotic medication in skin surgery.
    Callahan S; Goldsberry A; Kim G; Yoo S
    Dermatol Surg; 2012 Sep; 38(9):1417-26. PubMed ID: 22734794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative management of patients on chronic antithrombotic therapy.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():529-35. PubMed ID: 23233630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
    Kar S; Bhatt DL
    Coron Artery Dis; 2012 Sep; 23(6):380-90. PubMed ID: 22728913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple antithrombotic therapy: risky but sometimes necessary.
    Sørensen R; Gislason G
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):171-5. PubMed ID: 24774390
    [No Abstract]   [Full Text] [Related]  

  • 10. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
    Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
    Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 12. Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Kaye AD; Manchikanti L; Novitch MB; Mungrue IN; Anwar M; Jones MR; Helander EM; Cornett EM; Eng MR; Grider JS; Harned ME; Benyamin RM; Swicegood JR; Simopoulos TT; Abdi S; Urman RD; Deer TR; Bakhit C; Sanapati M; Atluri S; Pasupuleti R; Soin A; Diwan S; Vallejo R; Candido KD; Knezevic NN; Beall D; Albers SL; Latchaw RE; Prabhakar H; Hirsch JA
    Pain Physician; 2019 Jan; 22(1S):S75-S128. PubMed ID: 30717501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostasis. Part 2: Medications that affect haemostasis.
    McCormick NJ; Moore UJ; Meechan JG; Norouzi M
    Dent Update; 2014 Jun; 41(5):395-6, 399-402, 405. PubMed ID: 25073220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.
    Brown DG; Wilkerson EC; Love WE
    J Am Acad Dermatol; 2015 Mar; 72(3):524-34. PubMed ID: 25486915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative management of anticoagulation in elective surgery.
    McKenzie JL; Douglas G; Bazargan A
    ANZ J Surg; 2013 Nov; 83(11):814-20. PubMed ID: 23601136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of venous thromboembolism with dabigatran.
    Schulman S
    Curr Opin Pulm Med; 2012 Sep; 18(5):410-5. PubMed ID: 22617811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
    Morales-Vidal S; Schneck MJ; Flaster M; Biller J
    Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B; Faille D; Ajzenberg N
    Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative management of and recommendations for antithrombotic medications in dermatological surgery.
    Palamaras I; Semkova K
    Br J Dermatol; 2015 Mar; 172(3):597-605. PubMed ID: 25142961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.